igf-1 lr3 before and after female for Athletes: Safe Use Lean Gains Unlocking the Power of IGF-1

PMID: 11524632

Since these compounded medications are altered to be copycats, they may contain contaminants or impurities, inconsistent amounts of active ingredients, incorrect dosages, and even incorrect ingredients, leaving patients vulnerable to a variety of adverse effects

Muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage ( cholinergic crisis ) An important complication that can arise is obstruction of the airway by bronchial secretions Pharmacokinetics: IV and IM administration Rapid renal excretion, resulting in a short duration of action of 5-10 mins Major drug Interactions: Care should be given when administering this drug to patients with symptoms of myasthenic weakness who are also on anticholinesterase drugs Since symptoms of anticholinesterase overdose (cholinergic crisis) may mimic underdosage (myasthenic weakness), their condition may be worsened by the use of this drug Figure 2

J Clin Oncol 24 (3): 460-6, 2006